relutrigine

News

Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.

News

Sanofi's CEO says adding to the group's pipeline through M&A and licensing will be "critical" as it prepares for generic competition to Dupixent.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.